IOVERA SYSTEM
Total Payments
$1.0M
Transactions
685
Doctors
310
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $868,186 | 377 | 167 |
| 2019 | $166,116 | 308 | 157 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $523,472 | 16 | 50.6% |
| Consulting Fee | $334,970 | 117 | 32.4% |
| Unspecified | $74,758 | 21 | 7.2% |
| Education | $47,974 | 16 | 4.6% |
| Travel and Lodging | $27,565 | 93 | 2.7% |
| Food and Beverage | $22,434 | 417 | 2.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,129 | 5 | 0.3% |
Payments by Type
General
$959,544
664 transactions
Research
$74,758
21 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| AN OPEN LABEL TRIAL OF CRYONEUROLYSIS FOR IMPROVEMENTS IN PAIN, ACTIVITIES OF DAILY LIVING AND QUALITY OF LIFE IN PATIENTS WITH ANKLE OSTEOARTHRITIS. | Pacira Pharmaceuticals Incorporated | $41,441 | 0 |
| A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, SHAM-CONTROLLED STUDY ASSESSING OPIOID UTILIZATION, POSTOPERATIVE PAIN AND FUNCTION IN SUBJECTS UNDERGOING TOTAL KNEE ARTHROPLASTY TREATED WITH PRESURGICAL IOVERA?? OR SHAM IOVERA?? CRYONEUROLYSIS AND POSTSURGICAL MULTIMODAL PAIN REGIMEN (PREPARE) | Pacira Pharmaceuticals Incorporated | $13,382 | 0 |
| A POST-MARKET, PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY TO EVALUATE THE IOVERA DEVICE IN TREATING PAIN ASSOCIATED WITH TOTAL KNEE ARTHROPLASTY | Pacira CryoTech Incorporated | $11,125 | 0 |
| A Post-Market, Prospective, Randomized, Controlled Study to Evaluate the iovera Device in Treating Pain Associated with Total Knee Arthroplasty | Myoscience Inc. | $3,969 | 0 |
| A Post-Market, Prospective Study to Evaluate the Iovera Device in Treating Pain Associated With Anterior Cruciate Ligament Reconstruction | Pacira Pharmaceuticals Incorporated | $3,000 | 0 |
| A COMPARISON OF STANDARD OF CARE INTRAOPERATIVE PAIN MANAGEMENT VS LIPOSOMAL BUPIVACAINE FOR CARDIAC SURGERY PATIENTS | Pacira Pharmaceuticals Incorporated | $1,841 | 0 |
Top Doctors Receiving Payments for IOVERA SYSTEM — Page 13
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Sports Medicine | Fort Worth, TX | $12.82 | 1 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | San Antonio, TX | $12.81 | 1 |
| , MD | Spinal Cord Injury Medicine | La Place, LA | $12.47 | 1 |
| , M.D | Orthopaedic Surgery | North Chelmsford, MA | $12.35 | 1 |
| , MD | Orthopaedic Surgery | North Chelmsford, MA | $12.35 | 1 |
| , MD | Orthopaedic Surgery | Mckinney, TX | $12.07 | 1 |
| , MD | Orthopaedic Surgery | Stephenville, TX | $11.34 | 1 |
| , DO | Sports Medicine | Stephenville, TX | $11.34 | 1 |
| , M.D | Sports Medicine | Stephenville, TX | $11.34 | 1 |
| , M.D | Diagnostic Radiology | Stephenville, TX | $11.34 | 1 |
| , M.D | Diagnostic Radiology | Houston, TX | $11.29 | 1 |
Ad
Manufacturing Companies
- Pacira Pharmaceuticals Incorporated $870,732
- Pacira CryoTech Incorporated $98,805
- Myoscience Inc. $64,764
Product Information
- Type Device
- Total Payments $1.0M
- Total Doctors 310
- Transactions 685
About IOVERA SYSTEM
IOVERA SYSTEM is a device associated with $1.0M in payments to 310 healthcare providers, recorded across 685 transactions in the CMS Open Payments database. The primary manufacturer is Pacira Pharmaceuticals Incorporated.
Payment data is available from 2019 to 2020. In 2020, $868,186 was paid across 377 transactions to 167 doctors.
The most common payment nature for IOVERA SYSTEM is "Current or prospective ownership or investment interest" ($523,472, 50.6% of total).
IOVERA SYSTEM is associated with 6 research studies, including "AN OPEN LABEL TRIAL OF CRYONEUROLYSIS FOR IMPROVEMENTS IN PAIN, ACTIVITIES OF DAILY LIVING AND QUALITY OF LIFE IN PATIENTS WITH ANKLE OSTEOARTHRITIS." ($41,441).